Official UK procurement notice
Canakinumab · UK public procurement notice
Authority: Northern Health and Social Care Trust (Central government)
What is being bought
Published requirement descriptionThe intended contract is for the supply of Canakinumab to Northern Health and Social Care Trust for up to a maximum of 3 years
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 26 Jun 2025, 10:32 BST
- Last source update
- 3 Sept 2025, 10:22 BST
- Authority reference
DAC128/0525PM- FTS notice number
2025/S 000-053420- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0553efFind a Tender
- Why no open competition
- Single Suppliers Intellectual Property Exclusive Rights
- Published justification
Purchase of drugs which are subject to patent protection/Sole MA Holder, where no reasonable alternative or substitute exists.
Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract -
(a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and
(b)there are no reasonable alternatives to those goods, services or works.
- Risks
Previous spend on DAC totalling £99,278. Aggregate value is £219,278.
How it was run
Official notice- Submission deadline
- —
Timeline
18 Aug 2025 → 3 Sept 2025 · 2 dates- Standstill ends18 Aug 2025, 23:59 BST
- Notice published3 Sept 2025, 10:22 BST
Notice history
4 events · 3 releases on Find a Tender · since 26 Jun 2025- Transparency notice published26 Jun 2025, 10:32 BSTUK5
- Contract award notice published7 Aug 2025, 15:26 BSTUK6
- Contract signature expected19 Aug 2025, 23:59 BSTscheduled
- Contract details notice published3 Sept 2025, 10:22 BSTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITED19 Aug 2025 – 31 May 2028 | £120,000 | 4 Jul 2025 | Awarded |
Contracts
Canakinumab · NOVARTIS PHARMACEUTICALS UK LIMITED
- Signed
- 19 Aug 2025
- Value
- £120,000
- Period
- 19 Aug 2025 – 31 May 2028
- Status
- active
No agreed KPIs: Not applicable as contract value is less than £5 million
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- NOVARTIS PHARMACEUTICALS UK LIMITEDAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender